Stocks CVS Health Corp

More

  • *Deal with Walgreens more than replaces Philidor-Valeant CEO. Dec 15- Valeant Pharmaceuticals International Inc on Tuesday said it reached a deal to distribute its drugs through leading pharmacy chain Walgreens Boots Alliance Inc, boosting credibility with wary investors and sending its shares up 17 percent. The company said on Tuesday its arrangement...

  • Valeant strikes discount deal with Walgreens Tuesday, 15 Dec 2015 | 8:01 AM ET
    A woman on an escalator in a Walgreens store in New York.

    Valeant Pharmaceuticals has struck a deal to distribute some of its medicines at a discount through Walgreens pharmacies.

  • 1 in 4 US doctors can't treat this kind of patient Monday, 7 Dec 2015 | 4:00 PM ET
    Doctor house calls

    Up to 1 in 4 primary care doctors say they aren't well prepared to manage care for patients with multiple chronic conditions.

  • Oil falls towards 2015 low on OPEC inaction Monday, 7 Dec 2015 | 7:12 AM ET

    Meanwhile, U.S. stock futures were higher this morning, after the Dow surged 369 points, after Friday's solid jobs report and as ECB President Mario Draghi reassured markets.

  • Behind the tricky balance of drug price and supply Wednesday, 2 Dec 2015 | 10:25 AM ET

    The national conversation on drug prices is getting louder, and patients increasingly want a voice in that discussion.

  • NEW YORK, Nov 23- U.S. drug benefit manager CVS Health said on Monday it would add Amgen Inc's Repatha cholesterol treatment to its list of covered drugs for private plans over a competing treatment from Regeneron Pharmaceuticals and Sanofi SA. The FDA approved Repatha and Praluent, made by Regeneron and Sanofi, within weeks of each other last summer for patients...

  • CHICAGO, Nov 18- Target Corp on Wednesday reported a higher quarterly profit and raised the low end of its fiscal-year forecast, but its shares fell nearly 5 percent because of slower growth in online sales and margin pressures. Macy's Inc and Nordstrom Inc have reported similar problems. Target's gross margins were slightly lower than a year earlier because of...

  • Cramer: US just won the global trade war on China Wednesday, 11 Nov 2015 | 6:50 PM ET

    Jim Cramer has declared the U.S. the winner of the trade war on China. So what companies will do best in China?

  • ORLANDO, Nov 11- An experimental cholesterol fighter being developed by Alnylam Pharmaceuticals and The Medicines Co slashed levels of bad LDL cholesterol and remained effective for six months, according to data from a small, early stage study. The drug, called ALN-PCSsc, cut LDL by more than 50 percent in the 69- subject study presented at the American Heart...

  • 'Squawk Box' investor buys beaten-down tech stock Wednesday, 11 Nov 2015 | 6:00 AM ET
    Akamai display

    Paul Meeks, director of institutional investing at Saturna Capital, is scooping up shares of a recently beaten-down technology name.

  • Navellier: Buy this stock on the housing recovery Wednesday, 4 Nov 2015 | 10:57 AM ET
    Mohawk Industries truck.

    Louis Navellier, whose "Squawk Box" model portfolio is up 20 percent this year, believes Mohawk Industries will beat earnings.

  • Philidor to shutter as drug partnerships dissolve Monday, 2 Nov 2015 | 6:55 PM ET

    Philidor, a pharmacy facing backlash from accusations about Valeant Pharmaceuticals' business model, announced it would close.

  • Oct 30- Vertex Pharmaceuticals Inc said it received a subpoena from the U.S. Department of Justice in the third quarter related to its marketed medicines, seeking documents related primarily to its "good laboratory practices" in a bioanalytical lab. Separately, drugmaker Mylan NV and drugstore chain CVS Health Corp said in their quarterly filings that they had...

  • Vertex, Mylan, CVS subpoenaed by federal agencies Friday, 30 Oct 2015 | 6:00 PM ET

    Oct 30- Vertex Pharmaceuticals Inc said it received a subpoena from the U.S. Department of Justice in the third quarter, seeking documents related primarily to its "good laboratory practices" in a bioanalytical lab. Separately, drugmaker Mylan NV and drugstore chain CVS Health Corp said in their quarterly filings that they had also received subpoenas from...

  • *LinkedIn, AbbVie soar after results. Oct 30- U.S. stock indexes finished with their strongest monthly performances in four years on Friday, even as they dipped for the day amid a mixed bag of earnings reports. On Friday, CVS Health fell 4.8 percent to $98.78 after a disappointing profit forecast for 2016..

  • *LinkedIn, AbbVie soar after results. *KeyCorp down after agreeing to buy First Niagara. Shares of drugmaker AbbVie jumped 12.1 percent to $60.62, the biggest positive driver for the S&P 500 index, after posting better-than-expected quarterly profit and a strong long-term outlook.

  • Oct 30- Valeant Pharmaceuticals International Inc, seeking to allay investor concerns about its business practices, said Friday it is cutting ties with a specialty pharmacy called Philidor Rx Services accused of helping it inflate revenue. The news failed to stem Valeant's sliding share price, which lost another 12 percent on Friday even after Bill Ackman,...

  • Oct 30- Valeant Pharmaceuticals International said on Friday that it is cutting ties with pharmacy Philidor Rx Services and that the pharmacy was shutting down. Bloomberg on Thursday detailed wrongdoing in its processing of medical claims, building on earlier reports about business practices. Express Scripts, CVS Health and OptumRx, part of UnitedHealth...

  • *Q3 adjusted profit of $1.28/ share vs est $1.29. *Sees 2016 adjusted EPS $5.68- $5.88 vs est $6.02. Oct 30- CVS Health Corp gave a disappointing profit forecast for 2016, hurt by costs related to the acquisition of Target Corp's pharmacies and as its own pharmacy benefits management business expands in low-margin Medicare and Medicaid plans.

  • BOSTON, Oct 30- Hedge fund mogul William Ackman told his investors on Friday that he was confident in his bet on Valeant Pharmaceuticals but faulted the company for a weak response to fraud allegations that have sunk its stock. CVS Health Corp and Express Scripts dropped Philidor from their networks on Thursday. Ackman's Pershing Square Capital Management...